We are monitoring the impact of COVID-19 on Cell Therapy Technologies Market Get in touch with us for detailed analysis Know More
Pulished Date November, 2020
ID: 10418
Share on
Share on

Global Cell Therapy Technologies Market Size, Share, Trends & Growth Analysis Report – Segmented By Product, Cell Type, Process, End-User and Region (North America, Europe, Asia Pacific, Latin America, The Middle East, and Africa) – Industry Forecast (2020 to 2025)

Pulished: November, 2020
ID: 10418
Pages: 190

Cell Therapy Technologies Market Size (2020 to 2025)

Between 2020 to 2025, the global cell therapy technologies market is forecasted to record 16.2% CAGR and worth USD 7.12 Billion By 2025.

MARKET DRIVERS:

The rise of investments by the government in cell-based research is the primary driver of the cell therapy technologies market. On-going R & D in multiple countries to find more effective treatment procedures for the ever-growing incidence of chronic diseases is estimated to support the cell therapy technologies market. Available funding for cell-based research that helps market key players to develop innovative devices is a positive sign to the market growth rate. Many governments are adopting innovative methods and therapies to support stem cell research, favoring the market during the forecast period.

Additionally, a rising focus on personalized medicine is expected to boost the growth scope for the cell therapy technologies market. For treatment and prevention of disease, precision medicine is needed by taking account of individuals in genes, lifestyle, and environment.

MARKET RESTRAINTS:

The major restraint that is obstructing the growth of the market is the shortage of skilled professionals. Also, from the last few decades, a rapid increase in technology and the development of products also affecting the market due to a shortage of trained professionals to operate complex instruments like multi-mode readers and flow cytometers. Expert professionals will be needed to perform complex instruments with a wide range of data outputs. The shortage of skilled professionals is prime restraint in the cell therapy technologies market. 

Impact of COVID-19 on the Global Cell Therapy Technologies Market:

COVID-19 pandemic impacted every market as same as the cell therapy technology market. COVID-19 pandemic has a negligible negative impact on the cell therapy technology market. An increase in the need for efficient drugs or vaccines is growing due to the rapid spread of COVID-19 cases. While manufacturing vaccines, cell-based research is an essential step that helps in the growth of the market. Staring days of COVID-19 disrupted the supply chain by delaying clinical trials that impacted the market negatively. The market should be in a linear progression from the upcoming days.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2019 to 2025

Base Year

2019

Forecast Period

2020 to 2025

Segments Covered

By Product, Cell Type, Process, End-User and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the global cell therapy technologies market has been segmented & sub-segmented based on the product, cell type, process, end-user, and region.

Cell Therapy Technologies Market - By Product:

  • Consumables
  • Equipment
  • Cell Processing Equipment
  • Single-use Equipment
  • Other Equipment
  • Systems & Software

Based on the product, the Consumables segment accounts for the largest share in the cell therapy technologies market. Initiatives by the government to enhance cell-based research therapy and growing investments by the companies to develop advanced consumables products are the leading factors hiking the growth of this segment.

Cell Therapy Technologies Market - By Cell Type:

  • T-cells
  • Stem Cells
  • Other Cells 

The T-cell segment is holding a significant share in the cell therapy technologies market based on the cell type. An increase in demand for T-cell therapies and government initiatives are major key factors to drive the growth in this segment.

Cell Therapy Technologies Market - By Process:

  • Cell Processing
  • Cell Preservation, Distribution, and Handling
  • Process Monitoring and Quality Control

By process, cell processing is accounting for the largest share in the cell therapy technologies market. During the forecast period, the cell processing segment records a high compound annual growth rate in the cell therapy technologies market. Usage of cell therapy instruments and media is a major factor for significant growth.

Cell Therapy Technologies Market - By End User:

  • Biopharmaceutical & Biotechnology Companies and CROs
  • Research Institutes and Cell Banks

By the end-user segment, Biopharmaceutical & Biotechnology companies and CROs segment is accounting for the largest share and expecting a record of high compound annual growth rate in the cell therapy technologies market in 2020. The attributing factor is the high burden of chronic diseases and an increase in R&D activities.

Cell Therapy Technologies Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Geographically, the North American region was accounted for the largest share in 2019 and estimated to record a high compound annual growth rate in the global cell therapy technologies market during the forecast period. In the North American region, many leading companies are situated in the U.S., like the Institute for stem cell biology and regenerative medicine, Stanford University, Yale stem cell center. The presence of leading companies is playing a significant role as growth attributing factors. In addition to that, there is strong regulatory and financing support from the federal bodies to expand the market in the U.S. and Canada.

Asia-Pacific region is estimated to grow faster from 2020 to 2025 in the global cell therapy technologies market due to the availability of therapies at affordable prices and the growth of awareness among the public about healthcare entities. In the Asia-Pacific region, Japan is a leading country for cell therapy technology as it is attributing the fastest growth. Japan's government recognized that regenerative medicine and cell therapy play a vital role in the contribution of development in the cell therapy technologies market.

KEY MARKET PLAYERS:

Some of the companies playing a dominating role in the global cell therapy technologies market are Thermo Fisher Scientific Inc., Merck KGaA., MaxCyte, Danaher Corporation, Becton, Dickinson and Company, Lonza Group, Sartorius AG, Terumo BCT, Fresenius Medical Care AG & Co. KGaA, and Avantor, Inc.

HAPPENINGS IN THIS MARKET IN THE RECENT PAST:

  • In 2020, to develop the next generation of cell therapy manufacturing, a collaboration was made by Lonza (Switzerland) with IsoPlexis (U.S.).
  • In 2020, the acquisition was made by the Biopharma business from General Electric Company's life Sciences division (U.S.) Danaher with Biopharma business from General Electric Company's life sciences division that leads to new business Cytiva.
  • In 2019, to expand global bioproduction capabilities with the addition of large-volume liquid manufacturing capacity for cell culture media, an investigation was made by Therma Fisher Scientific in the Inchinnan site.
  1. INTRODUCTION
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. RESEARCH METHODOLOGY
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Report Overview
    1. Executive Summary
    2. Key Inferences
  4. Market Dynamics
    1. Impact Analysis
      1. Drivers
      2. Restraints
      3. Opportunities       
    2. Regulatory Environment
    3. Technology Timeline & Recent Trends
  5. Competitor Benchmarking Analysis
    1. Key Player Benchmarking                    
      1. Market share analysis      
      2. Products/Service
      3. Regional Presence               
    2. Mergers & Acquisition Landscape                     
    3. Joint Ventures & Collaborations
  6. MARKET SEGMENTATION
    1. By Product Type
      1. Consumables
      2. Equipment
      3. Cell Processing Equipment
      4. Single-use Equipment
      5. Other Equipment
      6. Systems & Software
      7. Y-o-Y Growth Analysis, By Product Type
      8. Market Attractiveness Analysis, By Product Type
      9. Market Share Analysis, By Product Type
    2. By Cell Type
      1. T-cells
      2. Stem Cells
      3. Other Cells
      4. Y-o-Y Growth Analysis, By Cell Type
      5. Market Attractiveness Analysis, By Cell Type
      6. Market Share Analysis, By Cell Type
    3. By Process
      1. Cell Processing
      2. Cell Preservation, Distribution, and Handling
      3. Process Monitoring and Quality Control
      4. Y-o-Y Growth Analysis, By Process
      5. Market Attractiveness Analysis, By Process
      6. Market Share Analysis, By Process
    4. By End-users
      1. Biopharmaceutical & Biotechnology Companies and CROs
      2. Research Institutes and Cell Banks
      3. Y-o-Y Growth Analysis, By End-User
      4. Market Attractiveness Analysis, By End-User
      5. Market Share Analysis, By End-User
  7. GEOGRAPHICAL ANALYSIS
    1. Introduction
      1. Regional Trends
      2. Impact Analysis
      3. Y-o-Y Growth Analysis
      4. Market Attractiveness Analysis
      5. Market Share Analysis
    2. North America
      1. Introduction
      2. United States
      3. Canada
    3. Europe
      1. Introduction
      2. U.K
      3. Spain
      4. Germany
      5. Italy
      6. France
      7. Rest of Europe
    4. Asia-Pacific
      1. Introduction
      2. China
      3. India
      4. Japan
      5. South Korea
      6. Australia and NZ
      7. Rest of APAC
    5. Latin America
      1. Introduction
      2. Brazil
      3. Argentina
      4. Mexico
      5. Rest of Latin America
    6. Middle East & Africa
      1. Introduction
      2. Middle-East
      3. Africa
  8. STRATEGIC ANALYSIS
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  9. MARKET LEADERS' ANALYSIS
    1. Thermo Fisher Scientific Inc.
      1. Overview
      2. Products
      3. Financials (subjected to availability based on company type)
      4. Recent Developments
      5. SWOT analysis
      6. Analyst View
    2. Merck KGaA.
    3. MaxCyte
    4. Danaher Corporation
    5. Becton, Dickinson and Company
    6. Lonza Group
    7. Sartorius AG
    8. Terumo BCT
    9. Fresenius Medical Care AG & Co. KGaA
    10. Avantor, Inc.
  10. COMPETITIVE LANDSCAPE
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, collaborations and Joint Ventures
    4. New Product Launches
  11. MARKET OUTLOOK AND INVESTMENT OPPORTUNITIES
  12. APPENDIX
  13. List of Tables
  14. List of Figures
  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of product, cell type, process and end-user along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

Cell Therapy Technologies Market

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample